Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey

Abstract We investigated menstrual irregularities after the first and second doses of the COVID-19 vaccine. Women answered a customised online questionnaire (ClinicalTrial.gov ID: NCT05083065) aimed to assess the vaccine type, the phase of the menstrual cycle during which the vaccine was administered, the occurrence of menstrual irregularities after the first and second doses, and how long this effect lasted. We excluded women with gynaecological and non-gynaecological diseases, undergoing hormonal and non-hormonal treatments, in perimenopause or menopause, as well as those who had irregular menstrual cycles in the last 12 months before vaccine administration. According to our data analysis, approximately 50–60% of reproductive-age women who received the first dose of the COVID-19 vaccine reported menstrual cycle irregularities, regardless of the type of administered vaccine. The occurrence of menstrual irregularities seems to be slightly higher (60–70%) after the second dose. Menstrual irregularities after both the first and second doses of the vaccine were found to self-resolve in approximately half the cases within two months. Based on these results, we suggest to consider these elements during the counselling of women who receive the COVID-19 vaccine, letting them know about the potential occurrence of temporary and self-limiting menstrual cycle irregularities in the subsequent month(s).

[1]  C. Favaro,et al.  Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination , 2022, Obstetrics and gynecology.

[2]  J. Carroll,et al.  Pregnant during the COVID-19 pandemic: an exploration of patients’ lived experiences , 2021, BMC Pregnancy and Childbirth.

[3]  Shelly Kamin-Friedman,et al.  Lessons from Israel's COVID-19 Green Pass program , 2021, Israel Journal of Health Policy Research.

[4]  A. Bergamo,et al.  Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data , 2021, Journal of Autoimmunity.

[5]  L. Roncati,et al.  COVID-19 "Green Pass": a Lesson on the Proportionality Principle from Galicia. , 2021, European journal of health law.

[6]  K. Clancy,et al.  Characterizing menstrual bleeding changes occurring after SARS-CoV-2 vaccination , 2021, medRxiv.

[7]  V. Male Menstrual changes after covid-19 vaccination , 2021, BMJ.

[8]  C. Comba,et al.  Triangle of COVID, anxiety and menstrual cycle , 2021, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[9]  F. Josephson Assessment report COMIRNATY Common name : COVID-19 mRNA vaccine ( nucleoside-modified ) Procedure No . EMEA / H / C / 005735 / II / 0062 Marketing authorisation holder ( MAH ) : BioNTech Manufacturing GmbH , 2021 .

[10]  F. Facchiano,et al.  Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy , 2020, Aging Clinical and Experimental Research.

[11]  G. Remuzzi,et al.  COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic , 2020, EBioMedicine.

[12]  T. Alanzi,et al.  A Comparative Study on the Strategies Adopted by the United Kingdom, India, China, Italy, and Saudi Arabia to Contain the Spread of the COVID-19 Pandemic , 2020, Journal of healthcare leadership.

[13]  Liming Cheng,et al.  Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age , 2020, Reproductive biomedicine online.

[14]  Liming Cheng,et al.  Analysis of sex hormone, menstruation and ovarian reserve in COVID-19 women of child-bearing age: a cross-sectional study , 2020, Reproductive BioMedicine Online.

[15]  G. Biviá-Roig,et al.  Analysis of the Impact of the Confinement Resulting from COVID-19 on the Lifestyle and Psychological Wellbeing of Spanish Pregnant Women: An Internet-Based Cross-Sectional Survey , 2020, International journal of environmental research and public health.

[16]  S. Ourselin,et al.  Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study , 2020, medRxiv.

[17]  Alistair R W Williams,et al.  Physiology of the endometrium and regulation of menstruation. , 2020, Physiological reviews.

[18]  Medicines And Healthcare Products Regulatory Agency , 2020, Definitions.

[19]  Z. Memish,et al.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.

[20]  Sadao Suzuki,et al.  C-di-GMP as an effective microneedle vaccine adjuvant candidate on mouse , 2018 .

[21]  Y. Shoenfeld,et al.  Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants , 2013, American journal of reproductive immunology.

[22]  COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE ( CHMP ) GUIDELINE ON CONDUCT OF PHARMACOVIGILANCE FOR MEDICINES USED BY THE PAEDIATRIC POPULATION , 2007 .

[23]  Gunther Eysenbach,et al.  Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES) , 2004, Journal of medical Internet research.

[24]  I. Kharat,et al.  Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH. , 1990, Contraception.

[25]  Bethany J Figg,et al.  National Institute of Child Health and Human Development , 2013 .